NCT06626386 Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
| NCT ID | NCT06626386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2024-09-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.
Eligibility Criteria
Inclusion Criteria: * Men aged from 45 to 70 years * Informed consent for PSA measurement for prostate cancer screening Exclusion Criteria: * Patients unable to give consent
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.